-
1.Hirano, S.; Ichikawa, S.; Matsuda, A.
Development of a highly
β-selective ribosylation reaction without using neighboring group participation: Total synthesis of (+)-caprazol, a core structure of caprazamycins.
J. Org. Chem. 2007, 72, 9936-9946. DOI: 10.1021/jo701699h
-
2.Inoue, N.; Shionoya, A.; Minakawa, N.; Ogawa, N.; Matsuda, A.
Amplification of 4´-thioDNA in the presence of 4´-thio-dTTP and 4´-thio-dCTP, and 4´-thioDNA-derected transcription in vitro and in mammalian cells.
J. Am. Chem. Soc. 2007, 129, 15424-15425. DOI: 10.1021/ja075953c
-
3.Hoshika, S.; Minakawa, N.; Shionoya, A.; Imada, K.; Ogawa, N.; Matsuda, A.
Study of modification pattern-RNAi activity relationships using siRNAs modified with 4´-thioribonucleosides; finding an effective modification irrespective of target sequence.
ChemBioChem, 2007, 8, 2133-2138. DOI: 10.1002/cbic.200700342
-
4.Murata, S.; Mizumura, Y.; Hino, K.; Ueno, Y.; Ichikawa, S.; Matsuda, A.
Modular bent DNAs: A new class of artificial DNAs with a protein binding ability.
J. Am. Chem. Soc. 2007, 129, 10300-10301. DOI: 10.1021/ja071335k
-
5.Yasui, H.; Inanami, O.; Asanuma, T.; Iizuka, D.; Nakajima, T.; Kon, Y.; Matsuda, A.; Kuwabara, M.
Treatment combining X irradiation and a ribonucleoside anticancer drug, 1-(3-
C-ethynyl-
β-
D-
ribo-pentofuranosyl)cytosine, synergistically suppresses the growth of tumor cells transplanted in mice.
Int, J. Rad. Oncol. Biol. Phys. 2007, 68, 218-228. DOI:10.1016/j.ijrobp.2006.12.061
-
6.
-
7.Ohtawa, M.; Ichikawa, S.; Teishikata, Y.; Fujimuro, M.; Yokosawa, H.; Matsuda, A.
9-(2-
C-Cyano-2-deoxy-
β-
D-
arabino-pentofuranosyl)guanine (CNDAG), a potent antitumor agent against B-lymphoma infected with Kaposi’s sarcoma-associated Herpesvirus (KSHV).
J. Med. Chem. 2007, 50, 2007-2010. DOI: 10.1021/jm070032y
-
8.Kazuno, H.; Shimamoto, Y.; Tsujimoto, H.; Fukushima, M.; Matsuda, A.; Sasaki, T.
Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
Oncology Rep. 2007, 17, 1453-1460. Abstract
-
9.Juan, E. C. M.; Kondo, J.; Kurihara, T.; Ito, T.; Ueno, Y.; Matsuda, A.; Takenaka, A.
Crystal structures of DNA:DNA and DNA:RNA duplexes containing 5-(N-aminohexyl)-carbamoyl-modified uracils reveal the basis for properties as antigene and antisense molecules.
Nucleic Acids Res. 2007, 35, 1969-1977. DOI: 10.1093/nar/gkl821
-
10.Kudoh, T.; Murayama, T.; Matsuda, A.; Shuto, S.
Substitution at the 8-position of 3´´-deoxy-cyclic ADP-carbocyclic-ribose, a highly potent Ca2+-mobilizing agent, provides partial agonist.
Bioorg. Med. Chem. 2007, 15, 3032-3040. DOI: 10.1016/j.bmc.2007.02.001
-
11.Hirano, S.; Ichikawa, S.; Matsuda, A.
Total synthesis of (+)-FR-900493 and establishment of its absolute stereochemistry.
Tetrahedron, 2007, 63, 2798-2804. DOI: 10.1016/j.tet.2007.01.055
-
12.Ichikawa, S.; Matsuda, A.
Nucleoside natural products and related analogs with potential therapeutic properties as antibacterial and antiviral agents.
Expert Opin. Ther. Patents 2007, 17, 487-498. DOI: 10.1517/13543776.17.5.487
-
13.Endo, Y.; Obata, T.; Nomura, M.; Fukushima, M.; Yamada, Y.; Matsuda, A.; Sasaki, T.
Development of an antitumor adenosine analog, 3´-ethynyladenosine.
Nucleosides, Nucleotides & Nucleic Acids 2007, 26, 691-694. DOI: 10.1080/15257770701490654
-
14.松田 彰
分子構造から考える薬物の作用機序 (3) 抗A型およびB型インフルエンザウイルス薬:ザナミビル水和物とリン酸オセルタミビル.
医薬ジャーナル, 2007, 43, 1-5.
-
15.猪上 尚徳,松田 彰
アプタマーと遺伝子暗号の拡張.
化学, 2007, 62, 64-65.
-
16.松田 彰,南川 典昭
核酸医薬の創製をめざして.
『バイオとナノの融合II,新生命科学への応用』, 北海道大学COE研究成果編集委員会編, 2007, pp187-199, 北海道大学.
-
17.南川 典昭,松田 彰
スーパー核酸:4´-チオ核酸の合成から核酸医薬開発に向けた基礎研究の展開.
化学フロンティア『創薬をめざす有機合成戦略:進化する医薬品づくり』, 宍戸宏造,新藤充編, 2007, pp157-164, 化学同人.